Tag: GlaxoSmithKline
-
Is GlaxoSmithKline a screaming buy after this news?
Following the results of a landmark drug trial, GlaxoSmithKline plc (LON: GSK) could be a screaming buy, says Rupert Hargreaves. More »
-
The GSK share price has soared 15%. Here’s why I think the FTSE 100 stock can’t be ignored
GlaxoSmithKline plc (LON: GSK) could offer stronger prospects than the FTSE 100 (INDEXFTSE: UKX). More »
-
To the lifeboats! 3 FTSE 100 stocks I think are perfect for volatile times like these
Royston Wild picks out three terrific FTSE 100 (INDEXFTSE: UKX) shares to load up on today. More »
-
Why I think it might finally be time to buy FTSE 100 dividend stock GlaxoSmithKline
Shares in drugmaker GlaxoSmithKline plc (LON:GSK) responded well to an update on trading. Paul Summers likes the stock a lot more than he used... More »
-
Is the GSK share price heading for 2,000p again?
After years of going nowhere, can GlaxoSmithKline plc (LON: GSK) shares be heading past the £2 barrier once more? More »
-
Why FTSE 100 growth stock NMC Health could trash the GSK share price
Roland Head compares the outlook for FTSE 100 (INDEXFTSE:UKX) healthcare stocks NMC Health plc (LON:NMC) and GlaxoSmithKline plc (LON:GSK). More »
-
Forget cash ISAs! Why bother when you can get 5.5% a year from investing in the GSK share price
Harvey Jones says that FTSE 100 (INDEXFTSE: UKX) pharmaceutical giant GlaxoSmithKline plc (LON: GSK) pays around six times the income you will get from... More »
-
Is the GlaxoSmithKline share price a bargain or should I buy this high-yielding small-cap?
Does this small-cap share’s recovery potential outshine the forward prospects of GlaxoSmithKline plc (LON: GSK)? More »
-
GSK and Sopheon’s share prices have beaten the FTSE 100 by 20%, is it time to buy?
Do GlaxoSmithKline plc (LON: GSK) and Sopheon plc (LON: SPE) offer further FTSE 100 (INDEXFTSE: UKX) outperformance potential? More »
-
Is this FTSE 250 faller set to bounce back and crush the GSK share price?
The GlaxoSmithKline plc (LON: GSK) share price has climbed in 2018, but here's one that could beat it in 2019. More »
-
FTSE 100 dividend stock GlaxoSmithKline isn’t the only healthcare star that could help you retire rich
Royston Wild explains why GlaxoSmithKline plc (LON: GSK) is just one London-quoted healthcare stock that could make you rich. More »
-
GlaxoSmithKline isn’t the only way to profit from the world’s ageing population
Edward Sheldon looks at a stock which, alongside GlaxoSmithKline plc (LON: GSK), could be set to benefit from the explosion in retirees across the... More »
-
3 FTSE 100 dividend stocks yielding 5%+ I’d buy for a new SIPP
Roland Head reveals his three top FTSE 100 (INDEXFTSE:UKX) picks for a starter pension portfolio. More »
-
Is the GSK share price primed to beat the FTSE 100?
Could GlaxoSmithKline plc (LON: GSK) deliver stronger total returns than the FTSE 100 (INDEXFTSE: UKX)? More »
-
GlaxoSmithKline isn’t the only pharmaceutical share I’d buy right now
Why I’m tempted by GlaxoSmithKline plc (LON: GSK) and this fast-growing pharmaceutical firm. More »
-
A soaring growth candidate plus a FTSE 100 dividend stock I’d buy today
Do you go for growth investing or do you seek dividend income? Here are two stocks that could deliver a combination of both. More »
-
Build a second income stream with these 2 terrific FTSE 100 dividend stocks
Royston Wild takes a look at two FTSE 100 (INDEXFTSE: UKX) dividend stars that could make you rich. More »
-
3 top FTSE 100 dividend stocks I’m buying right now
Rupert Hargreaves highlights his three favourite FTSE 100 (INDEXFTSE: UKX) dividend stocks. More »
-
Here’s why the GSK share price could climb while Spire Healthcare sinks by 20%+
GlaxoSmithKline plc (LON: GSK) appears to offer better investment potential than Spire Healthcare plc (LON: SPI). More »
-
Here’s why the GSK share price could be set to beat the FTSE 100
GlaxoSmithKline plc (LON: GSK) shares have been lagging the FTSE 100, but could 2018's comeback mark a new upward trend? More »